These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6764105)

  • 1. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
    Kotake T
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemotherapy of prostatic carcinoma.
    Beckley S; Wajsman Z; Slack N; Mittelman A; Murphy GP
    Scand J Urol Nephrol Suppl; 1980; 55():151-62. PubMed ID: 6938019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment for hormone-refractory or relapsing prostatic cancer].
    Hirao Y; Ozono S; Okajima E
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of trials of the USA National Prostatic Cancer Project.
    Elder JS; Gibbons RP
    Prog Clin Biol Res; 1985; 185A():221-42. PubMed ID: 3898131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of prostatic carcinoma].
    Wirth M; Altwein JE
    Urologe A; 1991 Jan; 30(1):17-24. PubMed ID: 2014582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum].
    Okumura S; Hasegawa J; Ohhara M; Kawamura N; Abe H; Yui Y; Kanamori S; Yoshida K; Nishimura T; Tomita M
    Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy: is it effective in treatment of prostatic cancer?
    Murphy GP
    Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of prostatic cancer.
    Schmidt JD
    Urol Clin North Am; 1975 Feb; 2(1):185-96. PubMed ID: 1093059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
    Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
    Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment of advanced prostate cancer.
    Ismail M; Gomella LG
    Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for non-hormone refractory prostate cancer.
    Winquist E
    Can J Urol; 2006 Feb; 13 Suppl 1():67-70. PubMed ID: 16526986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in cancer of the prostate].
    D'Acremont B; Gattegno B; Cohen L; Fiatte P; Lucaks B; Thibault P
    Ann Urol (Paris); 1990; 24(2):87-95. PubMed ID: 2190532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hormone refractory prostate cancer: current standards and future prospects.
    Oh WK; Kantoff PW
    J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for early chemotherapy for the treatment of metastatic disease.
    Lucas A; Petrylak DP
    J Urol; 2006 Dec; 176(6 Pt 2):S72-5. PubMed ID: 17084173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of systemic cytotoxic therapy for prostate cancer.
    Chang SS; Kibel AS
    BJU Int; 2009 Jan; 103(1):8-17. PubMed ID: 19040524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line chemotherapy for advanced hormone-refractory prostate cancer.
    Garmey EG; Sartor O; Halabi S; Vogelzang NJ
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):118-22, 127-32. PubMed ID: 18347563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.